Suppr超能文献

用于为政策决策提供信息的系统数据收集:整合第4区鹳计划(R4S)协作新生儿筛查数据库以改善华盛顿州的串联质谱新生儿筛查

Systematic Data Collection to Inform Policy Decisions: Integration of the Region 4 Stork (R4S) Collaborative Newborn Screening Database to Improve MS/MS Newborn Screening in Washington State.

作者信息

Fleischman Ashleigh, Thompson John D, Glass Mike

机构信息

Washington State Department of Health, Office of Newborn Screening, 1610 NE 150th Street, Shoreline, WA, 98155, USA,

出版信息

JIMD Rep. 2014;13:15-21. doi: 10.1007/8904_2013_266. Epub 2013 Nov 5.

Abstract

In the past 50 years, newborn screening (NBS) has grown significantly in the breadth of screening programs and the number of conditions tested for each baby. The adaptation of tandem mass spectrometry (MS/MS) technology to detect inherited metabolic diseases is arguably one of the most impactful advancements in NBS testing. The addition of new conditions to the screening panel and the rarity of these conditions pose challenges for NBS program development, improvement, and evaluation. The Region 4 Stork (R4S) project is an international collaborative NBS database and a resource for programs across the world to overcome these challenges. By pooling true-positive case and laboratory testing data, the R4S database provides insight into complex MS/MS profiles for these rare conditions. The Washington State NBS Program is integrating aspects of the R4S web application and utilizing R4S resources to examine current protocols, identify improvements, implement changes, and review outcomes. Washington uses R4S resources to choose informative analytes and evaluate cutoffs. The program also examines the performance of R4S tools that are designed to aid in evaluating a baby's MS/MS screening results. This article documents these efforts in utilizing a subset of the R4S tools to improve their program, demonstrating the flexibility of the application. Other NBS programs can use the knowledge Washington has gained to strengthen their ability to correctly identify babies with metabolic disorders and mitigate the impact of screening on babies and their families.

摘要

在过去50年里,新生儿筛查(NBS)在筛查项目的广度以及每个婴儿检测的疾病数量方面都有了显著增长。串联质谱(MS/MS)技术应用于遗传性代谢疾病检测,可以说是新生儿筛查检测中最具影响力的进展之一。在筛查项目中增加新的疾病以及这些疾病的罕见性,给新生儿筛查项目的开发、改进和评估带来了挑战。第4区鹳计划(R4S)项目是一个国际合作的新生儿筛查数据库,也是世界各地项目用以克服这些挑战的资源。通过汇集真阳性病例和实验室检测数据,R4S数据库为这些罕见疾病的复杂MS/MS谱提供了深入了解。华盛顿州新生儿筛查项目正在整合R4S网络应用程序的各个方面,并利用R4S资源来检查当前方案、确定改进措施、实施变革以及审查结果。华盛顿利用R4S资源来选择信息丰富的分析物并评估临界值。该项目还评估了旨在辅助评估婴儿MS/MS筛查结果的R4S工具的性能。本文记录了利用R4S工具的一个子集来改进其项目的这些努力,展示了该应用程序的灵活性。其他新生儿筛查项目可以利用华盛顿所获得的知识,来增强其正确识别患有代谢紊乱婴儿的能力,并减轻筛查对婴儿及其家庭的影响。

相似文献

2
Expanded Screening of One Million Swedish Babies with R4S and CLIR for Post-Analytical Evaluation of Data.
Int J Neonatal Screen. 2020 May 27;6(2):42. doi: 10.3390/ijns6020042. eCollection 2020 Jun.
3
Newborn screening for proximal urea cycle disorders: Current evidence supporting recommendations for newborn screening.
Mol Genet Metab. 2018 Jun;124(2):109-113. doi: 10.1016/j.ymgme.2018.04.006. Epub 2018 Apr 20.
5
The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005.
J Inherit Metab Dis. 2006 Feb;29(1):76-85. doi: 10.1007/s10545-006-0228-9.
6
9
How longitudinal observational studies can guide screening strategy for rare diseases.
J Inherit Metab Dis. 2022 Sep;45(5):889-901. doi: 10.1002/jimd.12508. Epub 2022 May 10.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验